Comparison of Physical Activity Measured by Accelerometer and Questionnaire in Patients with Lymphoma, Pancreatic, or Colorectal Cancer During Cancer Therapy

What this Trial Is About

Physical activity plays a key role in cancer therapy outcomes, but accurately measuring it can be challenging. Researchers are investigating how well two different methods measure physical activity in patients undergoing cancer treatment. This study compares a motion tracker (accelerometer) and a standardized questionnaire to see if there are differences in their assessments during cancer therapy, focusing on patients with lymphoma, colorectal, or pancreatic cancer. The goal is to determine the most effective way to assess physical activity in these patients. The study does not involve any interventions or treatments; it is observational. Participants will have their physical activity recorded using both an accelerometer device and by completing an international physical activity questionnaire at various times during their cancer therapy. The study compares the results from these two methods to evaluate their relative accuracy and usefulness. Participants will be monitored within one week after starting cancer therapy to compare the physical activity assessments. Researchers will collect and analyze data from both the motion tracker and the questionnaire. The study will also consider treatment types including surgery, chemotherapy, or radiotherapy. The total involvement duration is not specified, but the primary measurement focus is the first week after therapy initiation.

Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker